drugset
drugset / Trial / NCT03126214

Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing

NCT03126214 ↗

Phase 4 Completed 79 enrolled University of Alberta Canadian Stroke Prevention Intervention Network · collabHeart and Stroke Foundation of Canada · collab
RandomizedCrossoverOpen-labelPrevention

Summary

The purpose of this study is to compare the effectiveness of prescribing oral anticoagulation therapy by pharmacist intervention compared to enhanced usual care in participants with unrecognized AF and/or known AF but not taking blood thinners.

Timeline

Start
2018-02-01
Primary completion
2022-07-01
Completion
2023-12-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Warfarin Small molecule — Oral

Indications

atrial fibrillation stroke disorder